References

  1. Rey JM (editor). IACAPAP e-Textbook of Child and Adolescent Mental Health, Geneva. International Association for Child and Adolescent Psychiatry and Allied Professions. 2015. Google Scholar

  2. Woods G, Shannon C, Davidson G, Hoy K, Lewis D, Tumelty L, Mulholland C. Psychotropic prescribing patterns among adolescents in Northern Ireland presenting with psychotic symptoms during a 5-year period. Irish Journal of Psychological Medicine. 2016; 33(01):13-20. PubMed | Google Scholar

  3. Harrison JN, Cluxton-Keller F, Gross D. Antipsychotic medication prescribing trends in children and adolescents. Journal of Pediatric Health Care. 2012; 26(2):139-45. PubMed | Google Scholar

  4. Yu-Tao X, Yong-Zhen W, Chi?Ming L, Wai-Kwong T, Ungavri GS. Exploring the clinical and social determinants of prescribing anticholinergic medication for Chinese patients with schizophrenia. Human Psychopharmacology: Clinical and Experimental. 2007b; 22(3):173-80. PubMed | Google Scholar

  5. Rao P, Zepf FD, Chakrabarti I, Sigalas P. Atypical antipsychotic prescribing patterns amongst Child and Adolescent Mental Health Services clinicians in a defined National Health Service Trust. Translational Developmental Psychiatry. 2016; 4. PubMed | Google Scholar

  6. Tunde-Ayinmode MF. Audit of child and adolescent psychiatry in a teaching hospital in Nigeria: Prevalence, pattern and implication for improved services. South African Journal of Psychiatry. 2010 Mar 10;16(1). PubMed | Google Scholar

  7. Shekelle P, Maglione M, Bagley S, Suttorp M, Mojica WA, Carter J, Rolon C, Hilton L, Zhou A, Chen S, Glassman P. Efficacy and comparative effectiveness of off-label use of atypical antipsychotics.Comparative Effectiveness Review No 6. (Prepared by the Southern California/RAND Evidence-based Practice Center under Contract No. 290-02-0003.) Rockville, MD: Agency for Healthcare Research and Quality. January 200 Available at: www.effectivehealthcare.ahrq.gov/reports/final.cfm. Google Scholar

  8. Maher AR, Theodore G. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. Journal of Managed Care Pharmacy. 2012;18(5 Supp B):1-20. PubMed | Google Scholar

  9. Kukreja S, Kalra G, Shah N, Shrivastava A. Polypharmacy in psychiatry: a review. Mens sana monographs. 2013; 11(1):82. doi: 10.4103/0973-122104497. PubMed | Google Scholar

  10. Saldaņa SN, Keeshin BR, Wehry AM, Blom TJ, Sorter MT, DelBello MP, Strawn JR. Antipsychotic polypharmacy in children and adolescents at discharge from psychiatric hospitalization. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2014 Aug 1;34(8):836-44. PubMed | Google Scholar

  11. Comer JS, Olfson M, Mojtabai R. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007. Journal of the American Academy of Child & Adolescent Psychiatry. 2010 Oct 31;49(10):1001-10. PubMed | Google Scholar

  12. Agbonile IO, Famuyiwa O. Psychotropic drug prescribing in a Nigerian psychiatric hospital. International Psychiatry. 2009;96. PubMed | Google Scholar

  13. Adeponle AB, Obembe AO, Adeyemi SO, Suleiman GT. Polypharmacy in psychiatric outpatient practice in northern Nigeria. African journal of psychiatry. 2007; 10(4):215-8. PubMed | Google Scholar

  14. World Health Organization. Global Health Observatory. Data Repository. 2013. PubMed | Google Scholar

  15. World Health Organization. Mental health atlas 2011 Department of Mental Health and Substance Abuse. World Health Organization. Jordan. http://www.who.int/mentalhealth/evidence/atlas/profiles/jor_mh_profile.pdf Accessed March 2013;11. Google Scholar

  16. Murphy AL, Gardner DM, Cooke C, Kisely S, Hughes J, Kutcher SP. Prescribing trends of antipsychotics in youth receiving income assistance: results from a retrospective population database study. BMC psychiatry. 2013;13(1):1. PubMed | Google Scholar

  17. Kendall T, Hollis C, Stafford M, Taylor C. Recognition and management of psychosis and schizophrenia in children and young people: summary of NICE guidance. Bmj. 2013; 346:f150. PubMed | Google Scholar

  18. Harrison P, Cowen P, Burns T. Shorter Oxford textbook of psychiatry. Oxford University press. 2012; Sixth edition. PubMed | Google Scholar

  19. Castro-Fornieles J, Parellada M, Soutullo CA, Baeza I, Gonzalez-Pinto A, Graell M, Paya B, Moreno D, de la Serna E, Arango C. Antipsychotic treatment in child and adolescent first-episode psychosis: a longitudinal naturalistic approach. Journal of child and adolescent psychopharmacology. 2008; 18(4):327-36. PubMed | Google Scholar

  20. Haw C, Stubbs J. Off-label psychotropic prescribing for young persons in medium security. Journal of Psychopharmacology. 2009 May 7. PubMed | Google Scholar

  21. Pogge DL, Singer MB, Harvey PD. Rates and Predictors of Adherence with Atypical Antipsychotic Medication: AFollow-Up Study of Adolescent Inpatients. Journal of Child & Adolescent Psychopharmacology. 2005 Dec 1;15(6):901-12. PubMed | Google Scholar

  22. Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment of children and adolescents with antipsychotic drugs. Archives of general psychiatry. 2006;63(6):679-85. PubMed | Google Scholar

  23. Aparasu RR, Bhatara V. Patterns and determinants of antipsychotic prescribing in children and adolescents, 2003-2004. Current medical research and opinion. 2007; 23(1):49-56. PubMed | Google Scholar

  24. Otasowie J, Duffy R, Freeman J, Hollis C. Antipsychotic prescribing practice among child psychiatrists and community paediatricians. The Psychiatrist. 2010 Apr 1;34(4):126-9. PubMed | Google Scholar

  25. Russell PS, George C, Mammen P. Predictive factors for polypharmacy among child and adolescent psychiatry inpatients. Clin Pract Epidemiol Ment Health. 2006; 2:. PubMed | Google Scholar